(Q42977188)

English

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

scientific article published on July 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

prevention of HIV/AIDS

0 references

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

1

object named as

Stephen D Lawn

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

object named as

James J Lewis

5

0 references

2

object named as

Robin Wood

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Gavin J Churchyard

6

object named as

Gavin J Churchyard

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Katharina Kranzer

4

object named as

Katharina Kranzer

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

object named as

Kevin M De Cock

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

489-498

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Epidemiology of HIV-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk Factors for Tuberculosis in HIV-lnfected Persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Opportunities and challenges for HIV care in overlapping HIV and TB epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Proportion of tuberculosis transmission that takes place in households in a high-incidence area

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of tuberculosis in a high incidence urban community in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of tuberculosis transmission to children and adolescents in a community with a high prevalence of HIV infection among adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of tuberculosis during highly active antiretroviral therapy in high-income and low-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoration of cellular immunity against tuberculosis in patients coinfected with HIV-1 and tuberculosis with effective antiretroviral therapy: assessment by determination of CD69 expression on T cells after tuberculin stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS-related tuberculosis in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: a controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis epidemics driven by HIV: is prevention better than cure?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Eradication of Tuberculosis Infection by Isoniazid Chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Isoniazid preventive therapy and risk for resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The mortality and pathology of HIV infection in a west African city.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970078-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(10)70078-5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42977188&oldid=2104973822"